Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.verified

600276.SS

Price:

$61.65

Market Cap:

$393.27B

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.

Industry

Drug Manufacturers - General

IPO Date

2000-10-18

Stock Exchange

SHH

Ticker

600276.SS

The Enterprise Value as of December 2025 (TTM) for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is 352.98B

According to Jiangsu Hengrui Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 352.98B. This represents a change of 10.60% compared to the average of 319.16B of the last 4 quarters.

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Historical Enterprise Value (quarterly & annually)

How has 600276.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Jiangsu Hengrui Medicine Co., Ltd. over the last ten years is 254.22B. The current 352.98B Enterprise Value has changed 13.78% with respect to the historical average. Over the past ten years (40 quarters), 600276.SS's Enterprise Value was at its highest in in the December 2020 quarter at 582.39B. The Enterprise Value was at its lowest in in the March 2016 quarter at 72.26B.

Quarterly (TTM)
Annual

Average

254.22B

Median

248.54B

Minimum

74.85B

Maximum

581.18B

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jiangsu Hengrui Medicine Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 110.38%

Maximum Annual Enterprise Value = 581.18B

Minimum Annual Increase = -46.65%

Minimum Annual Enterprise Value = 74.85B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024266.10B0.22%
2023265.50B14.65%
2022231.57B-25.32%
2021310.08B-46.65%
2020581.18B52.73%
2019380.52B98.38%
2018191.81B22.50%
2017156.58B86.27%
201684.06B12.31%
201574.85B110.38%

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Average Enterprise Value

How has 600276.SS Enterprise Value performed in the past?

The current Enterprise Value of Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

254.39B

5-year avg

330.89B

10-year avg

254.22B

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Enterprise Value vs. Peers

How is 600276.SS’s Enterprise Value compared to its peers?

Jiangsu Hengrui Medicine Co., Ltd.’s Enterprise Value is greater than Zhangzhou Pientzehuang Pharmaceutical., Ltd (103.36B), greater than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (223.21B), greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (14.54B), greater than Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (2.57B), greater than Sichuan Kelun Pharmaceutical Co., Ltd. (47.69B), greater than Hunan Jingfeng Pharmaceutical Co.,Ltd. (7.14B), greater than WuXi AppTec Co., Ltd. (212.04B), greater than Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (2.23B), greater than Yifan Pharmaceutical Co., Ltd. (16.48B), greater than Zhejiang Zhenyuan Share Co., Ltd. (2.96B),

Build a custom stock screener for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Hengrui Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jiangsu Hengrui Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Jiangsu Hengrui Medicine Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

What is the 3-year average Enterprise Value for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

What is the 5-year average Enterprise Value for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

How does the current Enterprise Value for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) compare to its historical average?